Growth Metrics

Merck (MRK) EBT Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -25.97%
Dec 31, 2025 27.31%
Sep 30, 2025 20.04%
Jun 30, 2025 12.77%
Mar 31, 2025 8.99%
Dec 31, 2024 36.72%
Sep 30, 2024 11.75%
Jun 30, 2024 13.01%
Mar 31, 2024 13.08%
Dec 31, 2023 -22.74%
Sep 30, 2023 16.09%
Jun 30, 2023 -35.34%
Mar 31, 2023 22.10%
Dec 31, 2022 13.33%
Sep 30, 2022 78.09%
Jun 30, 2022 12.97%
Mar 31, 2022 19.40%
Dec 31, 2021 37.32%
Sep 30, 2021 12.77%
Jun 30, 2021 2.68%
Mar 31, 2021 12.96%
Dec 31, 2020 -38.62%
Sep 30, 2020 2.45%
Jun 30, 2020 27.70%
Mar 31, 2020 22.68%
Dec 31, 2019 -16.29%
Sep 30, 2019 9.51%
Jun 30, 2019 11.50%
Mar 31, 2019 7.96%
Dec 31, 2018 16.28%
Sep 30, 2018 11.81%
Jun 30, 2018 10.87%
Mar 31, 2018 -2.80%
Dec 31, 2017 7.09%
Sep 30, 2017 -38.20%
Jun 30, 2017 -1.87%
Mar 31, 2017 -4.39%
Dec 31, 2016 -23.37%
Sep 30, 2016 4.18%
Jun 30, 2016 -2.10%
Mar 31, 2016 -1.25%
Dec 31, 2015 19.53%
Sep 30, 2015 36.93%
Jun 30, 2015 -8.25%
Mar 31, 2015 16.45%
Dec 31, 2014 -1.86%
Sep 30, 2014 19.48%
Jun 30, 2014 19.59%
Mar 31, 2014 13.10%